We're hosting events nationwide (and virtually) to tackle the biggest questions in health and medicine.
"It was fantastic, so many industry and academic leaders on one stage - kudos to STAT for bringing it all together!"
Browse our upcoming events — or see the full list of events we have scheduled.
STAT+ Conversations: A conversation on drug pricing, policy, and access
Pharmalot columnist, Ed Silverman, will be joined by Gilead's former chief commerical officer, Jim Meyers, to discuss all things drug pricing, policy, and access, and as always, take your questions live.
TYPES OF EVENTS
We have something for everyone. Get in touch with us to learn how to sponsor an upcoming event.
When circumstances permit, we host multiple in-person events per year for STAT readers and subscribers around the country.View Upcoming Events
Join us for our weekly STAT+ conversations, deep-dive webinars on industry trends, or online events featuring industry experts.View Upcoming Virtual Events
Ranging from half-day to multi-day programming, and bring the biggest names in biopharma, policy, and technology to the stage.View Upcoming Summit
Take a peek at past events, and access session recordings if you weren’t able to join us live.
The 2020 STAT Summit
The coronavirus pandemic has reset our expectations of what is possible. New medicines and vaccines are being developed at a previously unimaginable pace and telemedicine has replaced the doctor’s office. The 2020 STAT Summit brought together some of the greatest minds in science and medicine to discuss the big question on everyone’s mind: What’s next?
The 2020 STAT Health Tech Summit
Breakthroughs in health and medicine are note just biological - they're technological. Check out highlights from the STAT Health Tech Summit, which featured top executives, policymakers, and researchers working at the intersection of health and technology.
How can digital health overcome its next hurdles?
STAT convened several leaders across the health tech industry for a virtual roundtable discussion on digital health technologies. Over the course of the hour-long event, the group discussed two key questions: “What are the biggest barriers facing new digital health technologies and how do we overcome them?”
The future of clinical trials
For decades, Robert Califf has been an evangelist for randomized trials. Now, there’s new room for innovation. He is joined by Matthew Herper, senior writer at STAT, to discuss how new technologies could change medical research without sacrificing rigor.
Receive a monthly newsletter about upcoming events and promotions from STAT and our partners.